-
Estimating the Future Burden of Unvaccinated Girls Against Human Papilloma Virus (HPV) in Europe: A Modeling Study
Sep 9, 2025, 16:22 PM -
Investigation of Patient Satisfaction With Home Nursing Care Among Recipients
Sep 9, 2025, 16:22 PM -
The Intercept of Real-World Evidence (RWE) Health Equity and Health Technology Assessment (HTA): A Structured Literature Review of Health Policy and Methodological Guidance
Sep 9, 2025, 16:22 PM -
Understanding the Consequences of International Reference Pricing on Cancer Immunotherapy in Europe: A 10-Year Price Corridor Analysis
Sep 9, 2025, 16:22 PM -
Gaps in JCA Guidance for Systematic Literature Reviews: A Comparative Review with Cochrane, EUnetHTA, and Major HTA Agencies' Standards
Sep 9, 2025, 16:22 PM -
The New Discount on Combination Drug Therapies in Germany: First Numbers and Assessment From a Payor Perspective
Sep 9, 2025, 16:22 PM -
Cross-Validation of the Glycated Hemoglobin HbA1c Translator: A Predictive Tool to Evaluate the Relationship Between Diabetes Complications and Associated Healthcare Costs
Sep 9, 2025, 16:22 PM -
Sex Differences in Characteristics and Treatment Patterns of Patients With Sleep Disorders in South Korea
Sep 9, 2025, 16:22 PM -
Inequity in Public Healthcare Utilization Among Persons With Disabilities in Bangladesh: A Benefit Incidence Analysis
Sep 9, 2025, 16:22 PM -
Win Ratio in the Presence of Censored Data: Can Probabilistic Variants Improve Robustness?
Sep 9, 2025, 16:22 PM -
Late Treatment in Adults With Neurogenic Bowel Dysfunction: A Retrospective Analysis of German Claims Data
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Cefiderocol for the Treatment of Confirmed MBL-Producing Pathogens in Italy
Sep 9, 2025, 16:22 PM -
AI-Driven Simulation of FDA DCOA Review to Inform Evidence Planning and Regulatory Strategy
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact Analysis of Noninvasive Prenatal Testing (NIPT) for the Identification of Fetal Chromosomal Aneuploidies in Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Comprehensive Clinical Evaluation of Drugs for Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sep 9, 2025, 16:22 PM -
Constructing a Dynamic Budget Impact Model: An AI Pretraining Approach for a New Parkinson's Disease Drug
Sep 9, 2025, 16:22 PM -
Economic and Organizational Impact of Subcutaneous Ocrelizumab in French Daily Hospitals
Sep 9, 2025, 16:22 PM -
Expanded Access to Oncology Therapies in Mexico: The Role of Bioequivalent Abiraterone and Axitinib
Sep 9, 2025, 16:22 PM -
A Novel Framework to Assess Noninferiority in National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) Where Network Meta-Analyses (NMAs) Report Nonstatistically Significant Differences
Sep 9, 2025, 16:22 PM -
Estimating Health Utility Decrements Associated With Chronic Disease Outcomes Using MEPS
Sep 9, 2025, 16:22 PM
